Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5753)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2022 (publication date) through Aug 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rajappa S, Rau KM, Dattatreya PS, Ramaswamy A, Fernandes P, Pruthi A, Cheng R, Lukanowski M, Huang YH. Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options? World J Hepatol 2022; 14(6): 1074-1086 [PMID: 35978665 DOI: 10.4254/wjh.v14.i6.1074] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i6/1074.htm |
| Number | Citing Articles |
| 1 |
Maen Abdelrahim, Abdullah Esmail. The use of durvalumab and tremelimumab after atezolizumab and bevacizumab in patients with hepatocellular carcinoma: case report and literature review. Immunotherapy 2025; : 1 doi: 10.1080/1750743X.2025.2539064
|
| 2 |
Phan Thị Hồng Đức, Nguyễn Như Thành, Nguyễn Hoàng Quý. Hiệu quả và tính an toàn điều trị ung thư biểu mô tế bào gan tiến xa sau thất bại điều trị bước một tại bệnh viện ung bướu thành phố Hồ Chí Minh. Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế 2024; (91): 14 doi: 10.38103/jcmhch.91.3
|